Esperancepharma
Houston, US · 2 known investors
Esperance develops targeted oncology therapeutics designed to selectively kill cancer cells, including chemotherapy-resistant cells, via a proprietary Cationic Lytic Peptide (CLYP) platform, membrane-disrupting peptides, and antibody drug conjugates. The company operates from Houston, Texas near the Texas Medical Center, with MD Anderson Cancer Center as a strategic partner.
Founders & leadership
HA
Hector AlilaNamed on SEC filing
RB
Ross BarrettNamed on SEC filing
PH
Peter HoangNamed on SEC filing
SD
Sonia DeggsNamed on SEC filing
CL
Carola LeuschnerNamed on SEC filing
Board
JL
Joseph LovettBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2019
▶$1MraisedJul 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedJul 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hector AlilaExecutive Officer, Director
- Ross BarrettDirector
- Joseph LovettDirector
- Peter HoangDirector
- Sonia DeggsExecutive Officer
- Carola LeuschnerExecutive Officer
- Offering amount
- $1M
- Amount sold
- $1M
- Proceeds to insiders
- $100K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Esperancepharma do?
- Esperance develops targeted oncology therapeutics designed to selectively kill cancer cells, including chemotherapy-resistant cells, via a proprietary Cationic Lytic Peptide (CLYP) platform, membrane-disrupting peptides, and antibody drug conjugates. The company operates from Houston, Texas near the Texas Medical Center, with MD Anderson Cancer Center as a strategic partner.
- Who are Esperancepharma's investors?
- Esperancepharma's investors include Research Corporation Technologies, Louisiana Funds.
- How much funding has Esperancepharma raised?
- Esperancepharma has disclosed $1M raised across 1 round.
- Where is Esperancepharma headquartered?
- Esperancepharma is headquartered in Houston, US.